SCHEMBL7661306

SCHEMBL7661306

OCCN(CCO)Cc1cncc(CN(CCO)CCO)c1

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 4/20 0.46
HTT P42858 3/20 0.46
SMN1; SMN2 Q16637 2/20 0.46
MAPT P10636 2/20 0.46
KDM4E B2RXH2 1/20 0.46
HPGD P15428 1/20 0.46
MAPK1 P28482 1/20 0.46
POLB P06746 2/20 0.39
CYP1A2 P05177 1/20 0.39
CYP2D6 P10635 1/20 0.39
CYP2C9 P11712 1/20 0.39
CYP2C19 P33261 1/20 0.39
NPSR1 Q6W5P4 1/20 0.39
TSHR P16473 1/20 0.37
HSD17B10 Q99714 1/20 0.37
BCHE P06276 1/20 0.37
MEN1 O00255 1/20 0.37
KMT2A Q03164 1/20 0.37
LMNA P02545 1/20 0.35
CDK1 P06493 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7662648 0.79 HSD17B10 (0.41) POLBHSD17B10
SCHEMBL14874503 0.76 MEN1 (0.57) ALDH1A1HTTSMN1; SMN2MAPTKDM4E
SCHEMBL7108658 0.74 BCHE (0.41) ALDH1A1HTTSMN1; SMN2MAPTKDM4E
SCHEMBL13888904 0.74 HTT (0.53) ALDH1A1HTTSMN1; SMN2MAPTKDM4E
SCHEMBL7650781 0.74 TSHR (0.30) TSHR
SCHEMBL7663487 0.72 PNP (0.34) ALDH1A1MAPTMAPK1TSHR
SCHEMBL24885675 0.70 ALDH1A1 (0.55) ALDH1A1HTTSMN1; SMN2MAPTKDM4E
SCHEMBL13337772 0.69 TDP1 (0.42) ALDH1A1MAPTKDM4E
SCHEMBL7107256 0.68 BCHE (0.43) ALDH1A1HTTSMN1; SMN2MAPTKDM4E
SCHEMBL79747 0.68 HTT (0.62) ALDH1A1HTTSMN1; SMN2MAPTKDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6399613-B1 N,N'-BIS(2-HYDROXYETHYL)PYRAZINE-2,5- OR -2,6-DICARBOXAMIDE; DIABETES AVENTIS PHARMA S.A. (FR) 2002-06-04 US claimed
US-6399613-B1 N,N'-BIS(2-HYDROXYETHYL)PYRAZINE-2,5- OR -2,6-DICARBOXAMIDE; DIABETES AVENTIS PHARMA S.A. (FR) 2002-06-04 US disclosed